Baker Brothers Advisors - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 25 filers reported holding PROQR THRAPEUTICS N V in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2016$1,042,000
-81.8%
212,698
-75.3%
0.01%
-80.8%
Q3 2016$5,739,000
-3.9%
860,464
-30.3%
0.05%
-17.5%
Q2 2016$5,973,000
-9.3%
1,234,095
-8.6%
0.06%
-8.7%
Q1 2016$6,587,000
-23.2%
1,349,719
+36.6%
0.07%
-2.8%
Q4 2015$8,578,000
-40.4%
988,2990.0%0.07%
-46.6%
Q3 2015$14,400,000
-12.6%
988,2990.0%0.13%
-8.3%
Q2 2015$16,475,000
+88.2%
988,299
+147.1%
0.14%
+98.6%
Q1 2015$8,752,000
+1.0%
400,0000.0%0.07%
-17.0%
Q4 2014$8,668,000
+26.1%
400,0000.0%0.09%
+1.1%
Q3 2014$6,876,000400,0000.09%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2016
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders